• OPEN AN ACCOUNT
Indian Indices
Sensex
72,963.33 580.86
( 0.80%)
Global Indices
Nasdaq
51,284.68 86.72
(0.17%)
Dow Jones
7,793.50 49.78
(0.64%)
Hang Seng
70,716.70 769.84
(1.10%)
Nikkei 225
10,489.44 27.49
(0.26%)
Forex
USD-INR
95.96 -0.21
(-0.22%)
EUR-INR
107.98 -0.51
(-0.47%)
GBP-INR
127.02 -0.14
(-0.11%)
JPY-INR
0.61 0.00
(-0.10%)

EQUITY - MARKET SCREENER

Deep Health AI India Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
539559
INE005G01026
3.5753222
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
4.49
22.63
EPS(TTM)
Face Value()
Div & Yield %
0.35
1
6.37
 

emco ltd
InvaGen receives EIR report for its facility in Hauppauge, New York
Aug 04,2026
Cipla announced that its wholly owned subsidiary, InvaGen Pharmaceuticals (InvaGen) has received the Establishment Inspection Report (EIR) from the USFDA, indicating the closure of the inspection of its manufacturing facility located at Hauppauge, Long Island, New York, USA.